Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine
- PMID: 1255476
Physiological disposition and biotransformation of [allyl-1', 3' - 14C naloxone in the rat and some comparative observations on nalorphine
Abstract
A sensitive method is described for the estimation of [14C]naloxone in biological materials. After a 1 mg/kg s.c. dose of [14C]naloxone to male Wistar rats, mean peak levels of drug in brain (506 ng/g) and plasma (119 ng/ml) were attained within 15 minutes. No persistence of drug in brain was observed at this dose. After a 10 mg/kg s.c. dose, the peak levels of naloxone in brain and plasma were 4.31 mug/g and 1.27 mug/ml, respectively, and extensive localization of extractable free drug and its minor metabolite, naloxol, occurred in tissues with high levels in kidney, spleen, lung, heart, skeletal muscle and somewhat lower concentration in the liver. The T1/2 of naloxone and nalorphine in rat brain and plasma with 1 and 10 mg/kg s.c. doses was 0.4 hour. With a 10 mg/kg dose, significant amounts of radioactivity persisted in tissues but not in plasma 96 hours after injection. The brain/plasma ratios and degree of plasma-protein binding were significantly higher for naloxone as compared to nalorphine. The amounts of free naloxone excreted as a percentage of the dose in urine and feces 96 hours after injection of the 10 mg/kg s.c. dose were 4.1 and 3.9 (for nalorphine 4.7 and 8.3); conjugated drug 15.4 and 1.2 (for nalorphine 13 and 0.9); total radioactivity 43.3 and 20.9 (for nalorphine 34.8 and 19.2), respectively. Naloxone-3-glucuronide (major), 3-sulfate (minor), naloxol and conjugated naloxol (minor), 7,8-dihydro-14-hydroxynormorphine, 7,8-dihydro-14-hydroxynormorphine and their conjugates were shown to be the metabolites of naloxone. In addition, tentative evidence was obtained for two polar hydroxylated metabolites (with hydroxylation presumably in the 17-side chain or in position 2 of the aromatic nucleus). 7,8-Dihydro-14-hydroxynormorphinone and 2-polar metabolites were also observed in brain. Rapid metabolism of naloxone and rapid elimination are important factors in its short duration of action. Possible relevance of these observations on differential antagonistic properties of these two antagonists are discussed.
Similar articles
-
Physiological disposition and biotransformation of (3H) cocaine in acutely and chronically treated rats.J Pharmacol Exp Ther. 1976 Mar;196(3):556-69. J Pharmacol Exp Ther. 1976. PMID: 1263111
-
Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.Drug Metab Dispos. 1976 May-Jun;4(3):276-80. Drug Metab Dispos. 1976. PMID: 6233
-
Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.Arzneimittelforschung. 1994 Apr;44(4):527-38. Arzneimittelforschung. 1994. PMID: 7912071
-
The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.Clin Pharmacokinet. 1976;1(3):219-30. doi: 10.2165/00003088-197601030-00004. Clin Pharmacokinet. 1976. PMID: 13957 Review.
-
Naloxone.2024 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000741 Free Books & Documents. Review.
Cited by
-
Supraspinal morphine and descending inhibitions acting on the dorsal horn of the rat.J Physiol. 1987 Mar;384:81-107. doi: 10.1113/jphysiol.1987.sp016444. J Physiol. 1987. PMID: 3309265 Free PMC article. Review.
-
Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.Psychopharmacology (Berl). 1992;107(1):89-96. doi: 10.1007/BF02244971. Psychopharmacology (Berl). 1992. PMID: 1317041
-
WIN 44,441: A Stereospecific and Long-Acting Narcotic Antagonist.Pharm Res. 1984 Jan;1(1):46-8. doi: 10.1023/A:1016386811268. Pharm Res. 1984. PMID: 24277186
-
Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats.Br J Pharmacol. 2003 Feb;138(4):689-97. doi: 10.1038/sj.bjp.0705102. Br J Pharmacol. 2003. PMID: 12598423 Free PMC article.
-
The antinociceptive action of etorphine in the dorsal horn is due to a direct spinal action and not to activation of descending inhibition.Br J Pharmacol. 1983 Feb;78(2):307-19. doi: 10.1111/j.1476-5381.1983.tb09396.x. Br J Pharmacol. 1983. PMID: 6338986 Free PMC article.